About us
Profile
Strategy
Business
Business fields
Markets & brands
Sustainability
History
Commitment at all levels: Our sustainability ambition of a “Healthier life” guides our daily actions.
Read more
Investor Relations
Investor hub
Newsroom
Financial publications
Investment highlights
Corporate governance
Governance principles
Board of Directors
Executive Board
General Meeting
Financial calendar
Share
Share information
Analysts & consensus
Bonds
Always up to date in our investor hub – the one-stop destination for all Group IR topics.
Learn more
News
Newsroom
News service
Press materials
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
Read more
Careers
Jobs
Areas of work
Locations
Culture
Diversity & inclusion
Leadership
Join the e-Health pioneers.
Learn more
News
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
9
Read more
Read more
24 Nov 2022
Corporate news
Zur Rose Group takes next step towards profitability and further reduces complexity in Germany
Read more
Read more
01 Nov 2022
Ad hoc announcement pursuant to Art. 53 LR
Procurement and supply chain brought together under the new Chief Operations Officer
Read more
Read more
20 Oct 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces results of Tender Offer
Read more
Read more
07 Oct 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces preliminary result and extension of Tender Offer
Read more
Read more
23 Sep 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023
Read more
Read more
13 Sep 2022
Corporate news
Final allocations of Zur Rose approx. CHF 95 million Convertible Bonds Offering
Read more
Read more
01 Sep 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process
Read more
Read more
31 Aug 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group launches approx. CHF 100 million Convertible Bonds and approx. CHF 50 million Capital Increase by way of an accelerated book building process
Read more
Search:
allform
All years
2022
2021
2020
2019
2018
2017
All news
Inside Information (AD-HOC Release)
Corporate News
DGAP-News
Aktuelle News
Press Release
All news
Ad hoc news
Corporate news
ZurRose
24 Nov 2022
Corporate news
Zur Rose Group takes next step towards profitability and further reduces complexity in Germany
Read more
ZurRose
01 Nov 2022
Ad hoc announcement pursuant to Art. 53 LR
Procurement and supply chain brought together under the new Chief Operations Officer
Read more
ZurRose
20 Oct 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces results of Tender Offer
Read more
20 Oct 2022
Corporate news
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
Read more
ZurRose
07 Oct 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces preliminary result and extension of Tender Offer
Read more
ZurRose
23 Sep 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023
Read more
ZurRose
13 Sep 2022
Corporate news
Final allocations of Zur Rose approx. CHF 95 million Convertible Bonds Offering
Read more
ZurRose
01 Sep 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process
Read more
ZurRose
31 Aug 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group launches approx. CHF 100 million Convertible Bonds and approx. CHF 50 million Capital Increase by way of an accelerated book building process
Read more
18 Aug 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group speeds up path to profitability and plans break-even at EBITDA level in 2023
Read more
ZurRose
31 May 2022
Corporate news
Betül Susamis Unaran leaves Zur Rose Group
Read more
ZurRose
28 Apr 2022
Corporate news
Zur Rose Group AG: Shareholders approve all proposals
Read more
ZurRose
20 Apr 2022
Corporate news
Zur Rose Group sees revenue perform as expected in the first quarter of 2022
Read more
ZurRose
06 Apr 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
Read more
ZurRose
24 Mar 2022
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued
Read more
ZurRose
20 Jan 2022
Corporate news
Zur Rose Group: steady growth in a volatile market environment
Read more
ZurRose
10 Jan 2022
Corporate news
Zur Rose Group nominates Rongrong Hu as director
Read more
ZurRose
09 Dec 2021
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share
Read more
ZurRose
08 Dec 2021
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities
Read more
ZurRose
28 Oct 2021
Corporate news
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Read more
ZurRose
21 Oct 2021
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
Read more
ZurRose
21 Oct 2021
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group continues to grow strongly
Read more
ZurRose
18 Aug 2021
Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent
Read more
ZurRose
29 Apr 2021
Corporate news
Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals
Read more
ZurRose
20 Apr 2021
Corporate news
Zur Rose Group signals dynamic revenue development in the first quarter of 2021
Read more
ZurRose
07 Apr 2021
Corporate news
Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021
Read more
ZurRose
18 Mar 2021
Corporate news
Zur Rose Group further extends European market leadership and successfully implements healthcare platform
Read more
ZurRose
21 Jan 2021
Corporate news
The Zur Rose Group accelerates growth
Read more
ZurRose
13 Jan 2021
Corporate news
Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty
Read more
ZurRose
11 Jan 2021
Corporate news
Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity
Read more
ZurRose
18 Dec 2020
Corporate news
The healthcare platform of the future: DocMorris+ is launched
Read more
ZurRose
14 Dec 2020
Corporate news
Local Pharmacy Strengthening Act circumvents ECJ ruling
Read more
ZurRose
10 Dec 2020
Corporate news
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
Read more
ZurRose
26 Nov 2020
Corporate news
New branding for a new vision: DocMorris
Read more
ZurRose
16 Nov 2020
Corporate news
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
Read more
ZurRose
21 Oct 2020
Corporate news
Zur Rose Group accelerates growth in third quarter 2020
Read more
ZurRose
08 Sep 2020
Corporate news
Zur Rose and KPT together launch digital medicines assistant Medi+
Read more
ZurRose
19 Aug 2020
Corporate news
Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy
Read more
ZurRose
17 Aug 2020
Corporate news
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
Read more
ZurRose
31 Jul 2020
Corporate news
Zur Rose Group successfully concluded acquisition of TeleClinic
Read more
ZurRose
17 Jul 2020
Corporate news
Zur Rose Group successfully completed capital increase from authorized capital and sets placement price
Read more
ZurRose
16 Jul 2020
Corporate news
Zur Rose Group AG resolves on capital increase from authorized Capital
Read more
ZurRose
16 Jul 2020
Corporate news
Zur Rose Group gives indications for half-year results
Read more
ZurRose
16 Jul 2020
Corporate news
Zur Rose Group acquires TeleClinic, Germany's leading telemedicine provider
Read more
ZurRose
26 Jun 2020
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
Read more
ZurRose
23 Apr 2020
Corporate news
2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals
Read more
ZurRose
20 Apr 2020
Corporate news
Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020
Read more
ZurRose
16 Apr 2020
Corporate news
Zur Rose Group starts 2020 with strong growth
Read more
ZurRose
02 Apr 2020
Corporate news
Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020
Read more
ZurRose
26 Mar 2020
Corporate news
Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
Read more
Load more
